Search research articles
Contact Us
Filters
Showing results (171-180 of 300) with videos related to
Page
of 30
Sort By:
British Journal of Haematology
|
April 23, 2014
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433
Jonathan W Friedberg, Joseph M Unger, W Richard Burack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo, Michelle Byrtek, Keith L Dawson, et al.
Blood Advances
|
June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
W Richard Burack, Hongli Li, Diana Adlowitz, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Follicular Lymphoma
Kami Maddocks, Paul M Barr, Bruce D Cheson, et al.
Leukemia & Lymphoma
|
December 24, 2013
Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy
Ajay K Gopal, Nancy L Bartlett, Andres Forero-Torres, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection
Gordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2015
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Ian W Flinn, Nancy L Bartlett, Kristie A Blum, et al.
Blood
|
November 15, 2014
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313
Daniel O Persky, Thomas P Miller, Joseph M Unger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2015
Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies
Jennifer L Kelly, Gilles Salles, Bryan Goldman, et al.
Cancer Discovery
|
August 30, 2018
<i>In Situ</i> Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J Frank, Patrick M Reagan, Nancy L Bartlett, et al.
Page
of 30
Search research articles
Search
Showing results (171-180 of 300) with videos related to
Sort By:
Page
of 30
British Journal of Haematology
|
April 23, 2014
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433
Jonathan W Friedberg, Joseph M Unger, W Richard Burack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo, Michelle Byrtek, Keith L Dawson, et al.
Blood Advances
|
June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
W Richard Burack, Hongli Li, Diana Adlowitz, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Follicular Lymphoma
Kami Maddocks, Paul M Barr, Bruce D Cheson, et al.
Leukemia & Lymphoma
|
December 24, 2013
Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy
Ajay K Gopal, Nancy L Bartlett, Andres Forero-Torres, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection
Gordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2015
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Ian W Flinn, Nancy L Bartlett, Kristie A Blum, et al.
Blood
|
November 15, 2014
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313
Daniel O Persky, Thomas P Miller, Joseph M Unger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2015
Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies
Jennifer L Kelly, Gilles Salles, Bryan Goldman, et al.
Cancer Discovery
|
August 30, 2018
<i>In Situ</i> Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J Frank, Patrick M Reagan, Nancy L Bartlett, et al.
Page
of 30